SUZANNE GAZDA M.D.
  • Home
  • Meet Dr. Gazda
    • Our Practice
  • Lectures/Videos
  • BLOGS
    • Blog - Long Covid
    • Blog - NEUROLOGY TRENDS
    • Blog - MS in the NEWS
    • Blog - Scientifically Speaking
    • Blog - Guest Articles
  • Our Approach
  • Conditions we treat
    • Alzheimer’s Disease
    • Amyotrophic Lateral Sclerosis (ALS)
    • Long COVID
    • Multiple Sclerosis (MS)
    • PANS | PANDAS
    • Parkinson’s disease
  • Treatment Protocols
  • Patient Stories
  • FAQ
  • Policies & Rates
  • Helpful LInks
  • Medical Resources
  • Journal Articles
  • Product Recommendations
  • Become a Patient
  • NEWS
  • Contact

Neurology
​Trends

Immune dysregulation requires rapid response to affect better outcomes.

11/28/2021

0 Comments

 

More findings point to efficacy of IVIG in PANS and PANDAS.

Imagine this scenario for a moment. Your house is on fire, but it seems confined to just one room. Would you wait to call the fire department? Of course not!  You would immediately take action to save your home. 
Picture
So, why would we wait to employ the most effective means available to quickly tamp down immune dysregulation and subsequent inflammation that drives virtually every disorder including PANS and PANDAS?
 
PANS or pediatric acute-onset neuropsychiatric syndrome and PANDAS, pediatric autoimmune neuropsychiatric disorder associated with streptococcus infection, can occur when our immune system, in mistaking normal cells for infectious agents, essentially launches an attack on our own tissues. The resulting impacts, which may develop very swiftly, can include obsessive compulsive disorder (OCD), motor tics, behavioral changes, eating disorders, and many other serious and often life-changing symptoms. It’s important to note too that while many PANS and PANDAS patients are between the ages of 3 and 13 years, there are instances where children (and young adults) outside that range have been affected.1 
 
But according to new data presented at the IgNS 2021 Conference “timely treatment with IV immunoglobulin (IVIG) therapy can help children who develop obsessive-compulsive disorder (OCD) and other severe psychiatric or neurologic symptoms in the aftermath of streptococcal or other infections.”
 
The key word here is TIMELY. And, as anyone involved in the care of PANS and PANDAS patients knows, there unfortunately can be significant delays in not only getting an accurate diagnosis, but also obtaining appropriate treatment. The disorders are often mistaken for other illnesses or patients initially may be seen by practitioners who just aren’t as familiar with these very complex disorders. Subsequently, the right therapies that could potentially help ward off more serious complications may not be employed from the start and this ultimately exacerbates the disease progression.
 
A recent article discussed the IgNS 2021 conference findings and offered insight from several physicians and researchers at prominent universities and medical centers that clearly stress the need for expedited care. Dr. Sydney Rice, University of Arizona (UA)/Banner Health Children’s Postinfectious Autoimmune Encephalopathy (CPAE) Center of Excellence - Tucson, cited the promising results from the use of IVIG as shown by Stanford University researchers, something with which Dr. Michael Daines, MD, an associate professor of pediatric allergy and immunology at the UA College of Medicine and the other CPAE Center co-director, concurred. 
 
Dr. Rice explained too that while the use of other therapies such as antibiotics and anti-inflammatories can help, they also may over-suppress the immune system. The multi-modality mechanisms of IVIG works to block the production of the antibodies that are at the root of the disorders, “so we use (it) in immunomodulatory doses to try to stop these antibodies from doing what they do.”
 
However, and something to which parents and clinicians can attest, getting IVIG approved by insurance providers is no easy task. The current costs for these treatments exceeds the costs for generic antibiotics or traditional anti-inflammatory therapies so it can be a long-waged challenge to obtain approval for something so many patients desperately need…at the expense of their health and prognosis.
 
There is no single or simple solution, but the message is clear – the sooner we put the out the fire and provide the RIGHT treatment for those affected by PANS, PANDAS, and other related auto-encephalopathy conditions, the sooner we can hope to see improvement and resolution of symptoms. 
 
The cost of delaying assessment and treatment is to our children’s futures – we must continue to work together toward making IVIG and other appropriate therapies more accessible and more quickly available! 
 
In hope and healing,
Dr. Suzanne Gazda 
 
To learn more about IVIG in PANS and PANDAS see: 
https://www.suzannegazdamd.com/blog/new-study-further-supports-benefits-of-ivig-treatment-in-pans-patients
 
For related resources and support groups, please see our Helpful Links section on our website.
 
You’ll also find numerous articles about PANS and PANDAS in our blog library; just use the Search tool on each page to locate more information by keyword and topic.
 
References

1 ASPIRE, Alliance to Solve PANS & Immune-Related Encephalopathies
https://aspire.care/what-is-pans/who-gets-pans/
 
Buckley, B. Pediatric OCD May Respond to Timely IG Therapy. Specialty Pharmacy Continuum® November 16, 2021. https://www.specialtypharmacycontinuum.com/Clinical/Article/11-21/Pediatric-OCD-May-Respond-to-Timely-IG-Therapy/65290
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    RSS Feed

    Author

    Dr. Suzanne Gazda, Integrative Neurology

    Archives

    February 2024
    January 2024
    November 2023
    August 2023
    July 2023
    June 2023
    May 2023
    April 2023
    March 2023
    December 2022
    November 2022
    September 2022
    April 2022
    November 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019

    Categories

    All

SITE MAP

HOME
MEET DR. GAZDA
OUR PRACTICE
INTEGRATIVE MEDICINE
OUR APPROACH
CONDITIONS WE TREAT
TREATMENT PROTOCOLS
PATIENT STORIES
FAQ
POLICIES & RATES
BLOG
SCIENTIFICALLY SPEAKING
MEDICAL RESOURCES
JOURNAL ARTICLES
LINKS
BECOME A PATIENT
CONTACT
NEWS
PRODUCT RECOMMENDATIONS

Location

San Antonio, Texas

Telephone

210-692-1245
Fax
210-692-9311

Email

[email protected]
  • Home
  • Meet Dr. Gazda
    • Our Practice
  • Lectures/Videos
  • BLOGS
    • Blog - Long Covid
    • Blog - NEUROLOGY TRENDS
    • Blog - MS in the NEWS
    • Blog - Scientifically Speaking
    • Blog - Guest Articles
  • Our Approach
  • Conditions we treat
    • Alzheimer’s Disease
    • Amyotrophic Lateral Sclerosis (ALS)
    • Long COVID
    • Multiple Sclerosis (MS)
    • PANS | PANDAS
    • Parkinson’s disease
  • Treatment Protocols
  • Patient Stories
  • FAQ
  • Policies & Rates
  • Helpful LInks
  • Medical Resources
  • Journal Articles
  • Product Recommendations
  • Become a Patient
  • NEWS
  • Contact